AtheroEdge™ Overview
AtheroEdge is 510 (K) cleared and is the first software on the market that offers fully-automated carotid IMT measurement by ultrasound. It is a fully automated c-IMT technology that completes in 5 seconds what semi-automatic systems do in several minutes.
Used By
- Neurologists
- Radiologists
- Vascular Surgeons
- Cardiologists
- Internists
- Endocrinologists
- Pediatricians
Applications
- Stroke
- Peripheral Vascular Disease
- Brain Degeneration
- Cardiovascular Disease
- Diabetes
- AtheroEdge Preview
- Evidence
- Service
- Diabetes & Atherosclerosis
-
Automated carotid intima-media thickness and its link for prediction of SYNTAX score in Japanese coronary artery disease patients.
Ikeda N, Saba L, Molinari F, Piga M, Meiburger K, Sugi K, Porcu M, Bocchiddi L, Acharya UR, Nakamura M, Nakano M, Nicolaides A, Suri JS.
-
Automated carotid IMT measurement and its validation in low contrast ultrasound database of 885 patient Indian population epidemiological study: results of AtheroEdge Software.
Molinari F, Meiburger KM, Zeng G, Saba L, Rajendra Acharya U, Famiglietti L, Georgiou N, Nicolaides A, Sriswan Mamidi R, Kuper H, Suri JS.
-
Carotid IMT variability (IMTV) and its validation in symptomatic versus asymptomatic Italian population: can this be a useful index for studying symptomaticity?
Saba L, Meiburger KM, Molinari F, Ledda G, Anzidei M, Acharya UR, Zeng G, Shafique S, Nicolaides A, Suri JS.
AtheroPoint provides services in form of processing the patient data through its propriety AtheroEdge™ software, to perform early diagnosis through speedy and accurate reporting. AtheroEdge™ estimates Lumen-Intima (LI) and Media-Adventitia (MA) borders and automatically measures the Intima-Media Thickness (IMT) of the longitudinal carotid artery images provided by the user.
Free Evaluation/Free Trial
The Company offers a free evaluation program for evaluating the product prior to purchasing. The Company will process up to 25 image frames of patients and provide the reports to the physician for assessment during the trial period.
Enrollment Options
After the evaluation period, physicians can enroll with the Company for 6 months, 12 months or longer term to process their patient image database. The service cost will vary depending upon the number of patients included in the database of the enrolling physician or office. All inquiries for quotes should be directed to sales@atherpoint.com.
At AtheroPoint we aim to revolutionize the screening, diagnosis, monitoring and management of cardiovascular disease (CVD). Call us today about AtheroEdge at 916-749-5628.
AtheroPoint™
Monitoring Made Simple